News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Robust CRO Market Is Driving New Merger and Acquisition Activity
Author(s)Jim Miller
The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.
Advertisement
Articles in this issue
over 21 years ago
In the Spotlight-December 2004over 21 years ago
Safety Problems Roil Pharma and FDAover 21 years ago
December 2004over 21 years ago
The Seventh Annual International Employment Surveyover 21 years ago
Pharmaco-FakeryAdvertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5